Vincent Luong

About me
Publications
CV
Public outreach and news

About me

MD (Resident), Hematology Unit, Karolinska University Hospital
PhD Student, Myeloma Group, MedH/HERM, Karolinska Institutet

Articles

Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(6):749-754
Conditioning with melphalan 200 mg/m² and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care
Afram G; Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(4):546-554
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups
Afram G; Susek KH; Uttervall K; Wersall JD; Wagner AK; Luong V; Lund J; Gahrton G; Alici E; Nahi H

All other publications

Conference publication: BLOOD. 2024;144(Supplement 1):3320
Outcomes of Relapsed and Refractory Multiple Myeloma with the Evolving Standard of Care
Luong V; Kashif M; Uttervall K; Bohlin A; Cetrez N; Afram G; Nahi H; Lund J; Alici E
Conference publication: BLOOD. 2024;144(Supplement 1):3318
A Lightweight Risk Scoring System for Stratification of Newly Diagnosed Multiple Myeloma Patients
Riga G; Luong V; Uttervall K; Gahrton G; Nahi H; Lund J; Alici E; Kashif M
Conference publication: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2024;24:S269-S270
P-407 Real-World Outcomes in Patients With Relapsed-Refractory Multiple Myeloma (RRMM) With Prior Proteasome Inhibitor and Lenalidomide Exposure in Sweden
Luong V; Kashif M; Uttervall K; Bohlin A; Fernström AÖ; Qu Y; Lee S; Mendes J; Van Hoorenbeeck S; Franck EH; He J; Alici E; Lund J
Conference publication: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2024;24:S269-S270
Real-World Outcomes in Patients With Relapsed-Refractory Multiple Myeloma (RRMM) With Prior Proteasome Inhibitor and Lenalidomide Exposure in Sweden
Luong V; Kashif M; Uttervall K; Bohlin A; Fernstrom AO; Qu Y; Lee S; Mendes J; Van Hoorenbeeck S; Franck EH; He J; Alici E; Lund J
Meeting abstract: BLOOD. 2023;142:1960
A Novel Biosignature for Potential Stratification and Elucidation of Newly Diagnosed Multiple Myeloma Patients at-Risk
Kashif M; Zhou Y; Luong V; Uttervall K; Gahrton G; Nahi H; Alici E; Lund J
Letter: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;110(2):224-225
Response to Caravita di Toritto and Rago
Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H; Afram G
Conference publication: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2022;22:S130
P-173: Prognostic utility of the evolving biomarkerbased progression model (e-model) for smoldering multiple myeloma (SMM) in a diverse population
Atrash S; Robinson M; Cassetta K; Varga C; Pineda-Roman M; Friend R; Paul B; Usmani S; Luong V; Voorhees P; Hareth N; Bhutani M
Conference publication: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2022;22:S130
Prognostic utility of the evolving biomarker-based progression model (e-model) for smoldering multiple myeloma (SMM) in a diverse population
Atrash S; Robinson M; Cassetta K; Varga C; Pineda-Roman M; Friend R; Paul B; Usmani S; Luong V; Voorhees P; Hareth N; Bhutani M
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(3):E63-E65
Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression
Gran C; Luong V; Bruchfeld JB; Liwing J; Afram G; Lund J; Usmani S; Alici E; Nahi H
Meeting abstract: BLOOD. 2016;128(22):563
Difference in Fibrin Clot Structure in Haemophilia A and Haemophilia B
Luong V; Soutari N; Berndtsson M; Holmstrom M; Antovic JP; Chaireti R

Employments

PhD Student | Affiliated to Research, Department of Medicine, Huddinge, Karolinska Institutet, 2023-2027

Degrees and Education

Degree Of Master Of Science In Medicine (MD), Karolinska Institutet, 2017

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI